Metastatic Trial Search Tutorial Videos: Now Available!
We are excited to announce that Metastatic Trial Search now includes a series of 10 brand-new tutorial videos covering the following topics: Introduction...
Read MoreMetastatic Breast Cancer Research Conference 2023
The Metastatic Breast Cancer Research Conference was held August 30 – September 1, 2023 in Park City, Utah. Click the links below to learn what was...
Read MoreHighlighting MBC Awareness Day and the MBC Alliance
October is Breast Cancer Awareness Month, and October 13 is MBC Awareness Day. This month, we are highlighting information about MBC Awareness Day as well as...
Read MoreOvercoming Resistance to CDK4/6 Inhibitors
The standard treatment for ER-positive, HER2-negative MBC is a combination of hormone therapy plus a CDK4/6 inhibitor: palbociclib (Ibrance®), ribociclib...
Read MoreWhat are Placebos and How Are They Used in MBC Clinical Trials?
A placebo, commonly called a sugar pill, is designed to look like the experimental drug but contains no medication. If you are considering enrolling in a clinical...
Read MoreNon-Treatment Trials: Surveys, Interviews, and Registries
Not all clinical trials study cancer treatments. Clinical trials also study ways to improve quality of life and reduce side effects, as well as collect...
Read MoreResearching Ways to Make MBC Treatment Easier to Tolerate
Tolerability is the ability to take a medication as recommended without experiencing side effects that cause you to stop taking it or take a reduced dose. Because...
Read MoreMeet the Clinical Trial Team: The Institutional Review Board
Clinical trials are run by a team, and we are continuing our series on the roles of clinical trial team members. This month, we are highlighting the Institutional...
Read MoreIn Memory of Dr. Susan Love
In July 2023, the breast cancer community lost a valued friend, advocate, surgeon, and researcher. Read below for a tribute to Dr. Susan Love. Dr. Susan...
Read MoreSEARCH OUR SITE
for past articles or specific information.